SPI Energy’s SolarJuice Celebrates Milestone of Surpassing 2GW of String Inverter Sales in Australia
2GW of string inverters is equivalent to 400K 5kW inverters SANTA CLARA, CA / ACCESSWIRE…
2GW of string inverters is equivalent to 400K 5kW inverters SANTA CLARA, CA / ACCESSWIRE…
Japanese Patent to Join U.S. and Korean Patents in AMY Battery Recycling Portfolio Remaining National…
XPhyto signs master supply agreement with operator of 10 COVID-19 test centers The test will…
VANCOUVER, BC / ACCESSWIRE / June 30, 2021 / Gold Mountain Mining Corp. (‘Gold Mountain’…
Louisiana-based online reputation management company DiamondLinks has changed its domain from DiamondLinks.net to DiamondLinks.com. NEW…
The Texas-based all-purpose smart home and security firm wishes to highlight that it offers the…
First Canadian company to be listed on the world’s first Technology Metals Market TORONTO, ON…
Levels of uncertainty are running high: the particularly contagious delta variant continues to spread. Although…
London | 30th June 2021 – Logicalis, an international IT solutions and managed services provider,…
24 Adventist Health hospital campuses will gain access to fast, seamless and secure Wi-Fi without…
New ‘Pay As You Go’ connectors have made legal document bundling faster, more efficient and…
Software gives organizations control and insight into their information security infrastructures to minimize vulnerabilities and…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., June 30, 2021 (GLOBE NEWSWIRE) —…
Press Release 30 June 2021 Change in Number of Shares and Votes in Immunicum AB…
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial…
PRESS RELEASE Emergex Receives Regulatory Approval for a Phase I Clinical Trial in Dengue of…
NANTES, France and FONTENAY-SOUS-BOIS, France, June 30, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173;…
-Two additional abstracts presented on data from ongoing clinical programs: Yselty for the treatment of…
Geneva, Switzerland, June 30, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering…
Results showed percutaneous implantation of allogeneic bone-forming cells was well tolerated in patients and led…